<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Sequenom Incorporated (Web)</title><link>http://www.zibb.com/all/theme/cq/Sequenom+Incorporated</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Sequenom+Incorporated" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Mon, 26 Oct 2009 10:40:30 GMT</pubDate><lastBuildDate>Mon, 26 Oct 2009 10:40:30 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Sequenom Incorporated (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Sequenom+Incorporated</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Sequenom Announces Paul Maier to Become Interim Chief Financial O...
      </title><link>http://www.bio-medicine.org/medicine-technology-1/Sequenom-Announces-Paul-Maier-to-Become-Interim-Chief-Financial-Officer-5705-1/</link><description>...SAN DIEGO Oct. 26 /- Sequenom Inc. (Nasdaq: ...(Logo: a href'http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO...Prior to the effective date of Mr. Maier's appointment as interim chie... I am delighted that Paul has agreed to join Sequenom as our interim</description><guid>http://www.bio-medicine.org/medicine-technology-1/Sequenom-Announces-Paul-Maier-to-Become-Interim-Chief-Financial-Officer-5705-1/</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate>Mon, 26 Oct 2009 10:40:30 GMT</pubDate><source url="http://www.bio-medicine.org" /></item><item><title>International PAG - Sequenom Vendor Workshop</title><link>http://www.intl-pag.org/10/10-sequenom.html</link><description>Tuesday Afternoon, 15 January 2002  4:00 pm - 6:15 pm Sequenom Workshop - Golden Ballroom Organizer: Tanya Boyaniwsky, Sequenom (tboyaniw@sequenom.com) Speakers: Christian Jurinke, Sequenom (cjurinke@sequenom.com) John McEwan, AgResearch (john.mcewan@agresearch.co.nz) Korena Paterson, AgResearch</description><guid>http://www.intl-pag.org/10/10-sequenom.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.intl-pag.org" /></item><item><title>Sequence Analysis Software</title><link>http://www.dddmag.com/product-iSEQ-Application-Software-708.aspx</link><description>Sequenom, Inc. a provider of genetic analysis solutions, announced the launch of the iSEQ™ application software, a MassARRAY® comparative sequence analysis application for automated, high-throughput identification and typing of microbes and viruses, as well as human disease-related molecular</description><guid>http://www.dddmag.com/product-iSEQ-Application-Software-708.aspx</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.dddmag.com" /></item><item><title>Video: In-Depth Look - Sequenom's Shocker - Zibb.com</title><link>http://www.zibb.com/article/5556404/Video+In+Depth+Look+Sequenom+s+Shocker</link><description>Interview and discussion with Raghuram Selvaraju of the Hapoalim Securities, talking about Sequenom's economic situation. (Bloomberg News) http://www.clipsyndicate.com/video/playlist/1998/1116869?cpt=8&amp;wpid=523</description><guid>http://www.zibb.com/article/5556404/Video+In+Depth+Look+Sequenom+s+Shocker</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate>Tue, 29 Sep 2009 13:46:07 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>Copyright © 2009 MarketWatch, Inc. All rights reserved. Please se...
      </title><link>http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&amp;Description=&amp;Image=&amp;symb=SQNM&amp;sid=2337927</link><description>Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.</description><guid>http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&amp;Description=&amp;Image=&amp;symb=SQNM&amp;sid=2337927</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.holdrs.com" /></item><item><title>Sequenom News Release</title><link>http://phx.corporate-ir.net/corporate.rss?c=84955&amp;Rule=Cat=news</link><description>httpphx.corporate-ir.net/phoenix.zhtml?c=84955&amp;p=irol-news&amp;nyo=0 A Collection of Sequenom News Release en-us Uncategorized Wed, 04 Nov 2009 21:17:11 GMT SEQUENOM Announces Date of Third Quarter 2009 Financial Results and Conference Call</description><guid>http://phx.corporate-ir.net/corporate.rss?c=84955&amp;Rule=Cat=news</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate>Sat, 29 Aug 2009 00:00:00 GMT</pubDate><source url="http://phx.corporate-ir.net" /></item><item><title>shopping or information</title><link>http://www.pehlemann.nl/news_antibody_genotyping_assay.asp</link><description>ELISA - Wikipedia, the free encyclopedia The Enzyme-Linked ImmunoSorbent Assay, or ELISA, is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. It uses two antibodies. One ...</description><guid>http://www.pehlemann.nl/news_antibody_genotyping_assay.asp</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.pehlemann.nl" /></item><item><title>Blood Tests Ease Search for Down Syndrome</title><link>http://www.nytimes.com/2008/10/07/health/research/07down.html?partner=rssnyt&amp;emc=rss</link><description>New powerful genetic techniques may provide an alternative to amniocentesis, which can cause miscarriages.</description><guid>http://www.nytimes.com/2008/10/07/health/research/07down.html?partner=rssnyt&amp;emc=rss</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate>Tue, 07 Oct 2008 06:58:54 GMT</pubDate><source url="http://www.nytimes.com" /></item><item><title>The Science of Newfound Genomics</title><link>http://www.newfound-genomics.com/science_partners.html</link><description>To further the understanding of genetics and its impact on human health, Newfound Genomics works in collaboration with a variety of world-class research and academic institutions. Affiliations have been established with such organizations as Sequenom and Memorial University of Newfoundland.</description><guid>http://www.newfound-genomics.com/science_partners.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.newfound-genomics.com" /></item><item><title>FuturePundit: Sequenom Searching For SNP Disease Risk Factors</title><link>http://www.futurepundit.com/archives/000461.html</link><description>Wired News writer David Ewing Duncan paid a visit to Sequenom of San Diego to become the first person to be tested for all known genetic markers that are thought to contribute to diseases.</description><guid>http://www.futurepundit.com/archives/000461.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.futurepundit.com" /></item><item><title>LIMS Finder: best site for laboratory informatics, LIMS products,...
      </title><link>http://www.limsfinder.com/BlogDetail.aspx?id=31764_0_3_0_C</link><description>Branford, CT – USA, January 23, 2007. GraphLogic Inc. announced today that its software applications built for biotechnology and pharmaceutical companies are fully compliant with CFR Part 11 and the applicable regulations.</description><guid>http://www.limsfinder.com/BlogDetail.aspx?id=31764_0_3_0_C</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.limsfinder.com" /></item><item><title>Sequenom Inc. - Analyst News | newratings.com</title><link>http://www.newratings.com/headlines/Sequenom-Inc-_US8173374054.html</link><description>Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.</description><guid>http://www.newratings.com/headlines/Sequenom-Inc-_US8173374054.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.newratings.com" /></item><item><title>Apria - resources - News</title><link>http://www.apria.com/resources/1,2725,494-873827,00.html</link><description>Following the proposal, each share of EXACT Sciences would be exchanged for USD1.50 in Sequenom common stock, subject to a floating exchange rate within a 15% collar, in which the price of Sequenom's common stock is between USD20.74 and USD28.06 per share.</description><guid>http://www.apria.com/resources/1,2725,494-873827,00.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.apria.com" /></item><item><title>SQNM - Sequenom, Inc. Stock Quotes, News, Stock Charts, Report .....
      </title><link>http://www.quotelinks.com/companies/sqnm.html</link><description>Stock quotes, news and charts for Sequenom, Inc. Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings,</description><guid>http://www.quotelinks.com/companies/sqnm.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.quotelinks.com" /></item><item><title>RT Magazine - The Journal for Respiratory Care Practitioners</title><link>http://www.rtmagazine.com/prnews.php?p=1052</link><description>to intellectual property for non-invasive prenatal gender testing through a licensing agreement with Isis Innovation Ltd., the technology transfer company of the University of Oxford.</description><guid>http://www.rtmagazine.com/prnews.php?p=1052</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.rtmagazine.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Sequenom reports revenues...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=26572</link><description>2006 APR 28 - (NewsRx.com) -- Sequenom, Inc. (SQNM) reported revenues for the fourth quarter were $4.4 million, compared to $6.1 million for the fourth quarter of 2004. Revenues for 2005 were $19.4 million, compared to $22.4 million for the prior year.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=26572</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Cytori Therapeutics</title><link>http://www.cytoritx.com/us/about/board_of_directors.html</link><description>Henriksen joined Cytori Therapeutics as Director in October 2002 and was previously a Board member of its predecessor, StemSource, Inc. Mr. Henriksen has more than 30 years of experience in healthcare, pharmaceutical, biotechnology and consulting and venture capital industries.</description><guid>http://www.cytoritx.com/us/about/board_of_directors.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.cytoritx.com" /></item><item><title>COLLEGEWARE USA INC et al v SEQUENOM INC - Legal Case Documents</title><link>http://www.legalcasedocs.com/120/252/679.html</link><description>, on behalf : 01-CV-10831 (SAS) of itself and all others : similarly situated, : 21 MC 92 (SAS) : Plaintiff, : : CLASS ACTION COMPLAINT -against- : FOR VIOLATIONS OF : FEDERAL SECURITIES LAW : SEQUENOM, INC., UBS WARBURG LLC, : FLEETBOSTON ROBERTSON STEPHENS, : INC.</description><guid>http://www.legalcasedocs.com/120/252/679.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.legalcasedocs.com" /></item><item><title>AAAA SmartBrief All Access - Genome Institute of Singapore Upgrad...
      </title><link>http://www.smartbrief.com/news/industryPR-detail.jsp?id=7FB69CE7-3F04-43E0-86FF-9365CDB32D5B</link><description>The GIS will also use Sequenom's epigenetic analysis solution, known as the EpiTYPER(TM) assay, for studying DNA methylation patterns, which are widely recognized to be key to understanding and potentially treating, various forms of cancer.</description><guid>http://www.smartbrief.com/news/industryPR-detail.jsp?id=7FB69CE7-3F04-43E0-86FF-9365CDB32D5B</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.smartbrief.com" /></item><item><title>Tata Group | TCS | Media reports | Genetic major Sequenom inks pa...
      </title><link>http://www.tata.com/tcs/media/20060801.htm</link><description>Sequenom Inc, the US' leading provider of genetic analysis solutions for molecular medicine and diagnostics, has entered into software development agreement with Tata Consultancy Services (TCS).</description><guid>http://www.tata.com/tcs/media/20060801.htm</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.tata.com" /></item><item><title>- Details of development stage by sector and equipment type. - Pi...
      </title><link>http://www.researchandmarkets.com/reports/605371/sequenom_inc_product_pipeline_analysis.pdf</link><description>- Details of development stage by sector and equipment type. - Pipeline products grouped by therapy area, development stage and trial phase. - Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.</description><guid>http://www.researchandmarkets.com/reports/605371/sequenom_inc_product_pipeline_analysis.pdf</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.researchandmarkets.com" /></item><item><title>MultiVu | NEW DATA SUPPORTS A NON-INVASIVE APPROACH TO ROUTINE PR...
      </title><link>http://www.prnewswire.com/broadcast/26578/consumer.shtml</link><description>This future diagnostic technology, currently under development at Sequenom, Inc. (Nasdaq: SQNM), shows promise that a universal alternative to such invasive genetic screening procedures as amniocentesis and chorionic villus sampling, may be available in the future.</description><guid>http://www.prnewswire.com/broadcast/26578/consumer.shtml</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.prnewswire.com" /></item><item><title>Technology/Bell Microproducts Inc. Equity Research</title><link>http://www.cariscompany.com/research/companyReportsByCategory.php?id=480&amp;idCategory=5</link><description>Bell Microproducts Inc., together with its subsidiaries, is a value-added distributor of storage products and systems, semiconductors and computer products and peripherals.</description><guid>http://www.cariscompany.com/research/companyReportsByCategory.php?id=480&amp;idCategory=5</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.cariscompany.com" /></item><item><title>Bloomberg.com: Investment Tools</title><link>http://www.bloomberg.com/apps/news?pid=conews&amp;tkr=SQNM:US</link><description>March 20, 2008 09:10 EDT -- The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker. Data is compiled thru firm releases.</description><guid>http://www.bloomberg.com/apps/news?pid=conews&amp;tkr=SQNM:US</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.bloomberg.com" /></item><item><title>San Diego Metropolitan - Cover Story - March 2000</title><link>http://www.sandiegometro.com/2000/mar/coverstory/sequenom.html</link><description>This is how it is in the hotbed of biotech investing: Sorrento Valley-based Sequenom Inc. (Nasdaq: SQNM) went public Feb. 1 at $26 a share. In two days, it quadrupled to $105; less than three weeks later at press time, the stock was $100.38. Market capitalization was $2.3 billion.</description><guid>http://www.sandiegometro.com/2000/mar/coverstory/sequenom.html</guid><category domain="http://www.zibb.com">Sequenom Incorporated</category><pubDate /><source url="http://www.sandiegometro.com" /></item></channel></rss>